Blanket Purchase Agreement GS35F0128Y-75F40121A00012

Award Date 4/22/21
Last Date to Order 4/25/26
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Clinger Cohen Act
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The Blanket Purchase Agreement was awarded by the Department of Health and Human Services Food and Drug Administration to Collabralink Technologies, Incorporated for CDER WORKFLOW MANAGEMENT PROGRAM (WFM) services. The single award contract has a potential value of $140 million and a period of performance through April 2026. The BPA aims to procure workflow management services to support the Center for Drug Evaluation and Research. Specifically, the prime contractor will deliver solutions for...
The Blanket Purchase Agreement was awarded by the Department of Health and Human Services Food and Drug Administration to Ignyte Group Inc. as a single-award contract under the Multiple Award Schedule. With a potential value of $140 million and a period of performance through April 2026, the BPA aims to procure CDER Workflow Management Program services. The CDER WFM BPA will provide services to support the Center for Drug Evaluation and Research's workflow management initiatives. This includes...
This Blanket Purchase Agreement (BPA) was awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Dullessystems Inc., a certified small business prime contractor. The $99,999,935 multiple-award BPA was established under the General Services Administration (GSA) Multiple Award Schedule (MAS) contract vehicle to provide regulatory review support services. The BPA aims to procure a wide range of IT modernization, operations and maintenance, and other professional services...
This Blanket Purchase Agreement (BPA) was awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Accenture Federal Services LLC, a global professional services company. The BPA, valued at up to $90 million, is for the provision of scientific, program management, and informatics governance modernization support services to the FDA's Center for Drug Evaluation and Research (CDER). Specific task orders issued under the BPA include a $13.4 million firm fixed-price...
The Blanket Purchase Agreement was awarded by the Department of Health and Human Services Food and Drug Administration to General Dynamics Information Technology, Inc. as a single award contract vehicle under the Multiple Award Schedule contracting vehicle. With a potential value of $90 million and a period of performance through October 2026, this BPA aims to procure scientific products and services in support of Executive Order 14042. The BPA's description indicates it was established to...
This Blanket Purchase Agreement (BPA) was awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Biswas Information Technology Solutions Inc., a minority and women-owned small business. The BPA is under the Multiple Award Schedule (MAS) contract vehicle and has a ceiling value of $99,999,935 with a period of performance through January 28, 2030. The purpose of this BPA is to provide regulatory review support services to the FDA. This includes modernizing FDA data...
The Blanket Purchase Agreement was awarded by the Department of Health and Human Services Food and Drug Administration to Booz Allen Hamilton Inc. as a single-award contract vehicle under the Multiple Award Schedule contracting vehicle. With a potential value of $90 million and a period of performance through October 2026, the BPA aims to procure scientific services in support of EO 14042 as described in the contract description. The BPA establishes an indefinite delivery/indefinite quantity...
This Blanket Purchase Agreement (BPA) contract was awarded by the Food and Drug Administration (FDA), a civilian agency, to the prime contractor Booz Allen Hamilton Inc., a prominent management and technology consulting firm. The contract has a ceiling value of $100,000,000 and a period of performance through July 31, 2027. The contract vehicle is the General Services Administration's (GSA) Multiple Award Schedule (MAS). The BPA contract is for Next Generation Regulatory Business Information...
The Blanket Purchase Agreement (BPA) awarded to Accenture Federal Services LLC by the Food and Drug Administration (FDA) is a single-award contract valued at up to $332,000,000 over its 6-year period of performance from October 2020 to September 2026. The contract was awarded under the General Services Administration's (GSA) Multiple Award Schedule (MAS) federal acquisition vehicle and is designated as a non-set-aside. The purpose of this BPA is to provide the FDA's Business Transformation...
The Department of Health and Human Services Food and Drug Administration awarded a single award Blanket Purchase Agreement to Rei Systems, Inc. under the Multiple Award Schedule contracting vehicle. With a potential value of $140 million and a period of performance through April 2026, this BPA aims to procure CDER Workflow Management Program services. The BPA will facilitate delivery of products and services to support the Center for Drug Evaluation and Research's workflow management...

The Blanket Purchase Agreement (BPA) was awarded by the Department of Health and Human Services Food and Drug Administration (FDA) to Technology Solutions Provider, Inc. as a single-award contract under the Multiple Award Schedule. With a potential value of $140 million, the BPA aims to procure workflow management services for the FDA's Center for Drug Evaluation and Research over a five-year period of performance ending in April 2026.

The BPA will facilitate task orders related to the CDER Workflow Management Program. This includes services to support the design, development, implementation and maintenance of solutions that manage review documentation and data associated with FDA's regulation of drugs, biologics and medical devices. By streamlining documentation workflows, the contracted services aim to enhance the efficiency and effectiveness of CDER's review processes.

Technology Solutions Provider, Inc. will deliver customized solutions and ongoing technical support services under individual task orders issued against the BPA. This allows the FDA to configure capabilities as needs evolve over the five-year ordering period. The single-award structure affords the agency flexibility while benefiting from the vendor's specialized experience in regulatory documentation and review processes.

Generated 1/4/24, 5:12 PM